effects [qlco]
Estrogen [horm, phsu, strd]
Raloxifene [orch, phsu]
Hormone replacement therapy [topp]
Serum [bdsu]
C-reactive protein [aapp, imft]
homocysteine levels [lbpr]
objectives [inpr]
To [qlco]
investigate [ftcn]
effects [qlco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
nomegestrol acetate [horm, phsu, strd]
Raloxifene [orch, phsu]
Serum [bdsu]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
homocysteine levels [lbpr]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Materials [sbst]
One [qnco]
Seven [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
prospective [resa]
randomized [resa]
placebo-controlled [resa]
months [tmco]
Study [mnob]
Received [qlco]
Daily [tmco]
Oral [spco]
mg% [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Nine [qnco]
Non [ftcn]
Women [popg]
One [qnco]
Four [qnco]
Group [idcn]
Group [idcn]
Patients [podg]
treated [topp]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Daily [tmco]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
Group [idcn]
Patients [podg]
treated [topp]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg% [qnco]
Daily [tmco]
Plus [qlco]
nomegestrol acetate [horm, phsu, strd]
Group [idcn]
Patients [podg]
treated [topp]
Raloxifene Hydrochloride [orch, phsu]
mg% [qnco]
Daily [tmco]
placebo [topp]
Group [idcn]
Patients [podg]
homocysteine [aapp, bacs]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Measured [qlco]
baseline [bodm]
months [tmco]
Result [ftcn]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
P NOS [aapp, imft]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Acetate [orch, phsu]
P NOS [aapp, imft]
Increased [qnco]
Serum C reactive protein level [lbpr]
High sensitivity [lbpr]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
nomegestrol acetate [horm, phsu, strd]
Decreased [qnco]
Serum [bdsu]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
P NOS [aapp, imft]
Raloxifene [orch, phsu]
Effect [qlco]
Serum C reactive protein level [lbpr]
High sensitivity [lbpr]
treatment [ftcn]
Active Treatment [topp]
Group [idcn]
Serum homocystine level [lbpr]
Decreased [qnco]
Compared [acty]
baseline [bodm]
placebo [topp]
Conclusions [idcn]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Therapies, Hormone Replacement [topp]
Raloxifene [orch, phsu]
Lower [spco]
Serum homocystine level [lbpr]
Extent [spco]
postmenopausal [tmco]
Women [popg]
cardiovascular risk factor [dsyn]
Not [ftcn]
Raloxifene [orch, phsu]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Increase [ftcn]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
treatment [ftcn]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
nomegestrol acetate [horm, phsu, strd]
Serum C reactive protein level [lbpr]
High sensitivity [lbpr]
[c] [qnco]
Ireland [geoa]
LTD [ortf]
Rights [qlco]
Reserve [acty]
